| Eye Associates Of Alexandria | |
|
120 12th Ave E, Alexandria, MN 56308 | |
| (320) 763-4321 | |
| (320) 763-6921 |
| Full Name | Eye Associates Of Alexandria |
|---|---|
| Type | Facility |
| Speciality | Optometrist |
| Location | 120 12th Ave E, Alexandria, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093891624 | NPI | - | NPPES |
| 030701053 | Other | PRIMEWEST | |
| 96477 | Other | PREFERRED ONE | |
| 942812700 | Other | MEDICAL ASSISTANCE | |
| 121754 | Other | U CARE | |
| 4C196BL | Other | BLUE CROSS | |
| CG3570 | Other | RR MEDICARE | |
| 61045BL | Other | BLUE CROSS | |
| 0373300001 | Other | DME | |
| 5982 | Other | HEALTH PARTNERS | |
| 2115931 | Other | MEDICA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | (* (Not Available)) | Primary |
| Provider Name | Jeremy R Anderson |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1205991692 PECOS PAC ID: 4082714647 Enrollment ID: I20100819001099 |
News Archive
A team of community leaders and researchers from UCLA and RAND has been awarded the 2014 Joint Team Science Award in recognition of a 10-year effort to conduct community engaged, population-based translational science to improve care for depression in low-income areas.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Science Translational Medicine on Wednesday published a commentary "authored by Harold Varmus, Nobel prize-winning director of the National Cancer Institute in the U.S., and by Harpal Kumar, CEO of Cancer Research U.K., on behalf of leading cancer research institutions from Australia to Argentina and Taiwan to Turkey," in which they describe a plan for addressing cancer in developed and developing countries, Guardian health editor Sarah Boseley reports in her "Global Health Blog."
› Verified 2 days ago
| Provider Name | Melissa K Hoven |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1346305737 PECOS PAC ID: 9436283868 Enrollment ID: I20100819001141 |
News Archive
A team of community leaders and researchers from UCLA and RAND has been awarded the 2014 Joint Team Science Award in recognition of a 10-year effort to conduct community engaged, population-based translational science to improve care for depression in low-income areas.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Science Translational Medicine on Wednesday published a commentary "authored by Harold Varmus, Nobel prize-winning director of the National Cancer Institute in the U.S., and by Harpal Kumar, CEO of Cancer Research U.K., on behalf of leading cancer research institutions from Australia to Argentina and Taiwan to Turkey," in which they describe a plan for addressing cancer in developed and developing countries, Guardian health editor Sarah Boseley reports in her "Global Health Blog."
› Verified 2 days ago
| Provider Name | John D Hoven |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1356404032 PECOS PAC ID: 8729188388 Enrollment ID: I20100819001194 |
News Archive
A team of community leaders and researchers from UCLA and RAND has been awarded the 2014 Joint Team Science Award in recognition of a 10-year effort to conduct community engaged, population-based translational science to improve care for depression in low-income areas.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Science Translational Medicine on Wednesday published a commentary "authored by Harold Varmus, Nobel prize-winning director of the National Cancer Institute in the U.S., and by Harpal Kumar, CEO of Cancer Research U.K., on behalf of leading cancer research institutions from Australia to Argentina and Taiwan to Turkey," in which they describe a plan for addressing cancer in developed and developing countries, Guardian health editor Sarah Boseley reports in her "Global Health Blog."
› Verified 2 days ago
| Provider Name | Carie L Stotesbery |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1285715904 PECOS PAC ID: 6800089780 Enrollment ID: I20101023000280 |
News Archive
A team of community leaders and researchers from UCLA and RAND has been awarded the 2014 Joint Team Science Award in recognition of a 10-year effort to conduct community engaged, population-based translational science to improve care for depression in low-income areas.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Science Translational Medicine on Wednesday published a commentary "authored by Harold Varmus, Nobel prize-winning director of the National Cancer Institute in the U.S., and by Harpal Kumar, CEO of Cancer Research U.K., on behalf of leading cancer research institutions from Australia to Argentina and Taiwan to Turkey," in which they describe a plan for addressing cancer in developed and developing countries, Guardian health editor Sarah Boseley reports in her "Global Health Blog."
› Verified 2 days ago
| Provider Name | Jenna R Kryder |
|---|---|
| Provider Type | Practitioner - Optometry |
| Provider Identifiers | NPI Number: 1225472244 PECOS PAC ID: 9830338235 Enrollment ID: I20130614000556 |
News Archive
A team of community leaders and researchers from UCLA and RAND has been awarded the 2014 Joint Team Science Award in recognition of a 10-year effort to conduct community engaged, population-based translational science to improve care for depression in low-income areas.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Science Translational Medicine on Wednesday published a commentary "authored by Harold Varmus, Nobel prize-winning director of the National Cancer Institute in the U.S., and by Harpal Kumar, CEO of Cancer Research U.K., on behalf of leading cancer research institutions from Australia to Argentina and Taiwan to Turkey," in which they describe a plan for addressing cancer in developed and developing countries, Guardian health editor Sarah Boseley reports in her "Global Health Blog."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Eye Associates Of Alexandria Po Box 789, 120 12th Ave E, Alexandria, MN 56308 Ph: (320) 763-4321 | Eye Associates Of Alexandria 120 12th Ave E, Alexandria, MN 56308 Ph: (320) 763-4321 |
News Archive
A team of community leaders and researchers from UCLA and RAND has been awarded the 2014 Joint Team Science Award in recognition of a 10-year effort to conduct community engaged, population-based translational science to improve care for depression in low-income areas.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted a patent for its novel anti-cancer compound, RX-3117.
An international team of researchers has found a group of mutations involved in T-cell acute lymphoblastic leukemia (T-ALL), and showed that a group of certain drugs, already in clinical use to treat other diseases, can eliminate the cells carrying these mutations.
Science Translational Medicine on Wednesday published a commentary "authored by Harold Varmus, Nobel prize-winning director of the National Cancer Institute in the U.S., and by Harpal Kumar, CEO of Cancer Research U.K., on behalf of leading cancer research institutions from Australia to Argentina and Taiwan to Turkey," in which they describe a plan for addressing cancer in developed and developing countries, Guardian health editor Sarah Boseley reports in her "Global Health Blog."
› Verified 2 days ago
Gess Eye Clinic P.a. Optometrist Medicare: Medicare Enrolled Practice Location: 109 15th Ave E, Alexandria, MN 56308 Phone: 320-762-5112 Fax: 320-763-3297 | |
Dr. Todd Donovan Olson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2306 S Broadway St, Alexandria, MN 56308 Phone: 320-763-7782 Fax: 320-763-0504 | |
Dr Eleanor S Haney Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 4611 Highway 29 S, Alexandria, MN 56308 Phone: 320-762-4044 Fax: 320-762-4046 | |
Runestone Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 3015 Highway 29 S, Suite 4155, Alexandria, MN 56308 Phone: 320-759-1130 | |
Dr. Jeremy R Anderson, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 120 12th Ave E, Alexandria, MN 56308 Phone: 320-763-4321 Fax: 320-763-6921 | |
Dr. Jenna Rose Kryder, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 1610 Broadway St, Alexandria, MN 56308 Phone: 320-763-4321 Fax: 320-763-6921 |